ES556550A0 - Un procedimiento para la preparacion de androsta -1-4-dien-3,17-dionas. - Google Patents

Un procedimiento para la preparacion de androsta -1-4-dien-3,17-dionas.

Info

Publication number
ES556550A0
ES556550A0 ES556550A ES556550A ES556550A0 ES 556550 A0 ES556550 A0 ES 556550A0 ES 556550 A ES556550 A ES 556550A ES 556550 A ES556550 A ES 556550A ES 556550 A0 ES556550 A0 ES 556550A0
Authority
ES
Spain
Prior art keywords
dionas
androsta
dien
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES556550A
Other languages
English (en)
Other versions
ES8801304A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10582036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES556550(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Publication of ES556550A0 publication Critical patent/ES556550A0/es
Publication of ES8801304A1 publication Critical patent/ES8801304A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES556550A 1985-07-09 1986-06-24 Un procedimiento para la preparacion de androsta -1-4-dien-3,17-dionas. Expired ES8801304A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858517360A GB8517360D0 (en) 1985-07-09 1985-07-09 Substituted androsta-1,4-diene-3,17-diones

Publications (2)

Publication Number Publication Date
ES556550A0 true ES556550A0 (es) 1987-12-16
ES8801304A1 ES8801304A1 (es) 1987-12-16

Family

ID=10582036

Family Applications (2)

Application Number Title Priority Date Filing Date
ES556550A Expired ES8801304A1 (es) 1985-07-09 1986-06-24 Un procedimiento para la preparacion de androsta -1-4-dien-3,17-dionas.
ES557466A Expired ES8802429A1 (es) 1985-07-09 1987-03-26 Un procedimiento para la preparacion de androsta-1,4-dien-3,17-dionas

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557466A Expired ES8802429A1 (es) 1985-07-09 1987-03-26 Un procedimiento para la preparacion de androsta-1,4-dien-3,17-dionas

Country Status (38)

Country Link
US (2) US4808616A (es)
JP (1) JPS6212797A (es)
KR (1) KR950003614B1 (es)
CN (1) CN86104664B (es)
AT (1) AT395157B (es)
AU (1) AU578840B2 (es)
BE (1) BE905067A (es)
BG (1) BG61370B2 (es)
BR (1) BR1100240A (es)
CA (1) CA1277656C (es)
CH (1) CH668599A5 (es)
CS (2) CS257794B2 (es)
CZ (1) CZ413591A3 (es)
DE (1) DE10199030I1 (es)
DK (1) DK163520C (es)
ES (2) ES8801304A1 (es)
FI (1) FI83424C (es)
FR (1) FR2584725B1 (es)
GB (2) GB8517360D0 (es)
GR (1) GR861780B (es)
HK (1) HK94190A (es)
HU (1) HU194274B (es)
IE (1) IE58949B1 (es)
IL (1) IL79336A (es)
IT (1) IT1196436B (es)
MY (1) MY102294A (es)
NL (2) NL193616C (es)
NO (2) NO165547C (es)
NZ (1) NZ216763A (es)
PH (1) PH21785A (es)
PT (1) PT82944B (es)
SE (1) SE468988B (es)
SG (1) SG80490G (es)
SK (1) SK413591A3 (es)
SU (2) SU1442077A3 (es)
UA (1) UA6046A1 (es)
YU (2) YU44585B (es)
ZA (1) ZA865079B (es)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones
GB8617107D0 (en) * 1986-07-14 1986-08-20 Erba Farmitalia 6-/7-methylenandrosta-1 4-diene-3 17-dione derivatives
GB8622330D0 (en) * 1986-09-17 1986-10-22 Erba Farmitalia 4-substituted 6-alkylidenandrostene-3,17-dione derivatives
DE3715869A1 (de) * 1987-05-07 1988-11-17 Schering Ag Verfahren zur herstellung von 1-methyl-androsta-1,4-dien-3,17-dion und die neuen zwischenprodukte fuer dieses verfahren
GB8721383D0 (en) * 1987-09-11 1987-10-21 Erba Farmitalia Preparation of methylene derivatives
GB8721384D0 (en) * 1987-09-11 1987-10-21 Erba Farmitalia 17-substituted andro-sta-1 4-dien-3-one derivatives
GB8801697D0 (en) * 1988-01-26 1988-02-24 Erba Farmitalia Improvements in synthesis of 6-methylene derivatives of androsta-1 4-diene-3 17-dione
EP0582713B1 (en) * 1991-03-28 1997-06-04 Teikoku Hormone Mfg. Co., Ltd. -New D-homo-17-oxa and D-homo-17-aza-androstane derivatives
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
GB9201224D0 (en) * 1992-01-21 1992-03-11 Erba Carlo Spa Difluoromethylenandrostenone derivatives and process for their preparation
NZ256130A (en) * 1992-09-30 1996-05-28 Teikoku Hormone Mfg Co Ltd 7-substituted oxasteroid derivatives; pharmaceutical compositions
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
GB9313420D0 (en) * 1993-06-29 1993-08-11 Erba Carlo Spa Fluorinated 6-methylenandrosta-1,4-dien-3-one-derivatives and process for their preparations
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
AU5873300A (en) * 1999-07-07 2001-01-30 Pharmacia & Upjohn Company Process to prepare exemestane
GB9930839D0 (en) * 1999-12-30 2000-02-16 Pharmacia & Upjohn Spa Process for treating gynecomastia
GB0005257D0 (en) * 2000-03-03 2000-04-26 Pharmacia & Upjohn Spa Breast cancer hormonal therapy
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
GB0017635D0 (en) * 2000-07-18 2000-09-06 Pharmacia & Upjohn Spa Antitumor combined therapy
AU2001283964A1 (en) * 2000-08-09 2002-02-18 Pharmacia And Upjohn Company Composition for combined use of aromatase inhibitors
US20040024044A1 (en) * 2000-09-08 2004-02-05 Di Salle Enrico Exemestane as chemopreventing agent
US20040082557A1 (en) * 2001-01-26 2004-04-29 Wajszczuk Charles Paul Methods for treating estrogen-dependent disorders
CA2434611A1 (en) * 2001-01-26 2002-09-19 Pharmacia Italia Spa Combined method for treating hormono-dependent disorders
EP2269603B1 (en) 2001-02-19 2015-05-20 Novartis AG Treatment of breast tumors with a rapamycin derivative in combination with exemestane
PL392652A1 (pl) 2001-05-16 2010-12-06 Novartis Ag Kombinacja zawierająca N-{5-[4-(4-metylo-piperazyno-metylo)-benzoiloamido]-2-metylofenylo}-4-(3-pirydylo)-2-pirymidyno-aminę oraz środek chemoterapeutyczny, jej zastosowanie, kompozycja farmaceutyczna ją zawierająca oraz zestaw zawierający taką kombinację
GB0120147D0 (en) * 2001-08-17 2001-10-10 Metris Therapeutics Ltd Treatment method
US20040043938A1 (en) * 2001-11-06 2004-03-04 Dinesh Purandare Combination therapy for estrogen-dependent disorders
GB0128510D0 (en) * 2001-11-28 2002-01-23 Novartis Ag Organic compounds
CN1652757B (zh) 2002-05-16 2012-02-08 诺瓦提斯公司 Edg受体结合剂在癌症中的应用
CN1304413C (zh) * 2002-10-24 2007-03-14 上海华拓医药科技发展有限公司 一种抗癌药物依西美坦制备方法
CN1317293C (zh) * 2002-10-24 2007-05-23 南京长澳医药科技有限公司 一种依西美坦的合成工艺
US20040186160A1 (en) * 2002-12-13 2004-09-23 Sugen, Inc. Hexahydro-cyclohepta-pyrrole oxindole as potent kinase inhibitors
WO2005027916A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
US20050101579A1 (en) * 2003-11-06 2005-05-12 Shippen Eugene R. Endometriosis treatment protocol
US8183401B2 (en) * 2004-01-16 2012-05-22 Cedarburg Pharmaceuticals, Inc. Exemestane and its intermediates and methods of making the same
US7435757B2 (en) * 2004-07-02 2008-10-14 Schering Ag 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
US10174070B2 (en) 2005-09-30 2019-01-08 Endece Llc 6-substituted estradiol derivatives and methods of use
US8168621B2 (en) 2005-09-30 2012-05-01 Endece, Llc 6-substituted estradiol derivatives and methods of use
US20080119447A1 (en) * 2005-09-30 2008-05-22 James Yarger 6-alkoxyalkyl estradiol derivatives and methods of use
JP5255444B2 (ja) 2005-09-30 2013-08-07 エンディース エルエルシー （ｓ）−６−メチルオキサアルキルエキセメスタン化合物および関連する使用方法
DE102006008074B4 (de) * 2006-02-22 2013-08-14 RUHR-UNIVERSITäT BOCHUM Behandlung von Krebs mit Geruchsrezeptor-Liganden
BRPI0711385A2 (pt) 2006-05-09 2011-11-08 Novartis Ag combinação compreendendo um quelante de ferro e um agente anti-neoplástico e seu uso
WO2008033466A2 (en) * 2006-09-14 2008-03-20 Combinatorx (Singapore) Pre. Ltd. Compositions and methods for treatment of viral diseases
US20080275259A1 (en) * 2007-05-04 2008-11-06 Scinopharm Taiwan, Ltd Process for preparing aromatase inhibitors
JP5558358B2 (ja) 2007-10-16 2014-07-23 レプロス セラピューティクス インコーポレイティド メタボリック症候群用のｔｒａｎｓ−クロミフェン
EP2070943A1 (en) * 2007-12-14 2009-06-17 Crystal Pharma, S.A. Process for obtaining 6-Alkylidenandrost-1,4-diene-3one
CN101468023B (zh) * 2007-12-26 2011-02-02 上海复星医药（集团）股份有限公司 依西美坦片及其制备工艺
WO2009093262A2 (en) * 2008-01-21 2009-07-30 Cadila Healthcare Limited Process for preparing aromatase inhibitor exemestane
GB0813628D0 (en) * 2008-07-25 2008-09-03 Arrow Int Ltd Stable coated anti-cancer agent
WO2010076811A2 (en) * 2008-12-30 2010-07-08 Ind-Swift Laboratories Limited Process for the preparation of exemestane
EP2429299B1 (en) 2009-05-01 2016-06-01 Celloxess Llc Treating male infertility secondary to sperm oxidative stress
DE102010003494A1 (de) * 2010-03-31 2011-10-06 Bayer Schering Pharma Aktiengesellschaft Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose
EP2556082B1 (en) 2010-04-08 2017-02-22 Emory University Substituted androst-4-ene diones
JP2013525296A (ja) 2010-04-16 2013-06-20 ノバルティス アーゲー 内分泌療法抵抗性乳癌の処置
SG188396A1 (en) 2010-09-14 2013-04-30 Endece Llc 6-substituted demethyl-estradiol derivatives as er-beta agonists
CA2865234A1 (en) 2012-02-29 2013-09-06 Repros Therapeutics Inc. Combination therapy for treating androgen deficiency
KR20160110963A (ko) 2014-02-11 2016-09-23 노파르티스 아게 암 치료를 위한 pi3k 억제제를 포함하는 제약 조합물
AU2016352592B2 (en) 2015-11-10 2023-04-27 Paracrine Therapeutics Ab Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and an anti estrogen
CN112409432B (zh) * 2020-11-16 2023-07-07 陕西理工大学 一种依西美坦的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB929985A (es) *
US2744120A (en) * 1953-01-14 1956-05-01 Olin Mathieson 1-dehydrotestololactone
US3112305A (en) * 1960-11-07 1963-11-26 British Drug Houses Ltd 6-methylene-3-oxo-delta4-steroids and process for their preparation
GB1042291A (en) * 1961-11-08 1966-09-14 Organon Labor Ltd í¸-6ª‡-amino steroids and the preparation thereof
DK120154B (da) * 1968-02-29 1971-04-19 Schering Ag Fremgangsmåde til fremstilling af N-substituerede 4-amino-3-oxosteroid-4,6-diener af androstan- eller pregnanrækken eller deres ammoniumsalte.
BE759143A (fr) * 1969-11-19 1971-05-19 Upjohn Co Procede de preparation d'un nouveau compose steroide
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
DE3004508C2 (de) * 1980-02-05 1981-12-10 Schering Ag Berlin Und Bergkamen, 1000 Berlin Verfahren zur Herstellung von 6-Methylensteroiden
DE3322285A1 (de) * 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
US4512986A (en) * 1983-07-26 1985-04-23 Research Triangle Institute Progrestationally active steroids
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones

Also Published As

Publication number Publication date
YU120186A (en) 1988-02-29
IE861821L (en) 1987-01-09
GB2177700B (en) 1988-12-07
GR861780B (en) 1986-11-11
NO165547C (no) 1991-02-27
FR2584725A1 (fr) 1987-01-16
IL79336A (en) 1991-06-10
HK94190A (en) 1990-11-23
FI862871A0 (fi) 1986-07-07
UA6046A1 (uk) 1994-12-29
NO862753L (no) 1987-01-12
PH21785A (en) 1988-02-24
YU44585B (en) 1990-10-31
SE8603046L (sv) 1987-01-10
IT8621004A0 (it) 1986-07-02
NZ216763A (en) 1988-05-30
DK163520C (da) 1992-07-27
HUT42780A (en) 1987-08-28
FI83424C (fi) 1991-07-10
FR2584725B1 (fr) 1988-05-13
GB8616585D0 (en) 1986-08-13
CZ413591A3 (en) 1994-03-16
BR1100240A (pt) 1999-12-28
SU1501923A3 (ru) 1989-08-15
JPS6212797A (ja) 1987-01-21
NO2000009I1 (no) 2000-10-05
ES8802429A1 (es) 1988-06-01
US4904650A (en) 1990-02-27
YU103687A (en) 1988-08-31
YU44628B (en) 1990-10-31
PT82944B (pt) 1989-01-30
NO862753D0 (no) 1986-07-08
BG61370B2 (bg) 1997-06-30
DE10199030I1 (de) 2001-10-04
ATA181986A (de) 1992-02-15
NL193616C (nl) 2000-04-04
JPH0443919B2 (es) 1992-07-20
SK413591A3 (en) 1995-07-11
IT1196436B (it) 1988-11-16
MY102294A (en) 1992-05-15
NL300017I1 (nl) 2000-11-01
AU5979986A (en) 1987-01-15
GB8517360D0 (en) 1985-08-14
ZA865079B (en) 1987-03-25
ES8801304A1 (es) 1987-12-16
NL300017I2 (nl) 2001-01-02
CN86104664A (zh) 1987-02-18
SU1442077A3 (ru) 1988-11-30
AT395157B (de) 1992-10-12
NL8601785A (nl) 1987-02-02
US4808616A (en) 1989-02-28
DK324386D0 (da) 1986-07-08
ES557466A0 (es) 1988-06-01
FI83424B (fi) 1991-03-28
DK163520B (da) 1992-03-09
FI862871A (fi) 1987-01-10
SE468988B (sv) 1993-04-26
CS258498B2 (en) 1988-08-16
BE905067A (fr) 1987-01-08
CA1277656C (en) 1990-12-11
GB2177700A (en) 1987-01-28
KR870001140A (ko) 1987-03-11
NL193616B (nl) 1999-12-01
SE8603046D0 (sv) 1986-07-08
PT82944A (en) 1986-08-01
HU194274B (en) 1988-01-28
IL79336A0 (en) 1986-10-31
CN86104664B (zh) 1988-06-29
KR950003614B1 (ko) 1995-04-17
IE58949B1 (en) 1993-12-01
AU578840B2 (en) 1988-11-03
CH668599A5 (de) 1989-01-13
CS521486A2 (en) 1987-09-17
DK324386A (da) 1987-01-10
SG80490G (en) 1990-11-23
NO165547B (no) 1990-11-19
CS257794B2 (en) 1988-06-15

Similar Documents

Publication Publication Date Title
ES556550A0 (es) Un procedimiento para la preparacion de androsta -1-4-dien-3,17-dionas.
ES551249A0 (es) Un procedimiento para la preparacion de peptidilaminodioles.
ES555834A0 (es) Un procedimiento para la preparacion de nuevas piranopiridinas.
ES556738A0 (es) Un procedimiento para la preparacion de nuevos piridazinaminas.
ES554405A0 (es) Un procedimiento para la preparacion de derivados de aza-indol.
ES545464A0 (es) Un procedimiento para la preparacion de tetrahidroftalimidas.
ES540705A0 (es) Un procedimiento para la preparacion de 17b-carbamoil-n-monosustituido -o 17b-acil-4-aza-5-alfa-androstien-3-onas.
ES553044A0 (es) Un procedimiento para la preparacion de nuevos derivados de fenoxialquilaminopirimidina.
ES544644A0 (es) Un procedimiento para la preparacion de derivados de carboxamidoadenosina.
ES556127A0 (es) Un procedimiento para la preparacion de quinolinas 2-sustituidas.
ES540901A0 (es) Un procedimiento para la preparacion de derivados de n,n-pipericinilo disustituidos.
ES546236A0 (es) Un procedimiento para la preparacion de derivados de bencimidasol.
ES554983A0 (es) Un procedimiento para la preparacion de silileteres.
ES542703A0 (es) Un procedimiento para la preparacion de derivados de tiazol,2, 4, disustituidos.
ES552189A0 (es) Un procedimiento para la preparacion de derivados de piridimilmidazolidiona.
ES540609A0 (es) Un procedimiento para la preparacion de pirazolo piridinas.
ES544521A0 (es) Un procedimiento para la preparacion de triazolobenzodiazefinas.
ES540610A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES546872A0 (es) Un procedimiento para la preparacion de aminoalcoxibenzopiranonas.
ES552297A0 (es) Un procedimiento para la preparacion de nuevos derivados de disacaridos o trisacaridos.
ES541781A0 (es) Un procedimiento para la preparacion de nuevos benzotiopenos.
ES550504A0 (es) Un procedimiento para la preparacion de derivados de podofilotoxina.
ES544751A0 (es) Un procedimiento para la preparacion de -1-metilcarbapenems.
ES553874A0 (es) Un procedimiento para la preparacion de metanosulfonatos de dioxolano.
ES555369A0 (es) Un procedimiento para la preparacion de un polialquenoilisocianato.

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20071008